ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
159 hedge funds and large institutions have $195M invested in Antares Pharma, Inc. in 2020 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 56 increasing their positions, 46 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
19% less call options, than puts
Call options by funds: $311K | Put options by funds: $386K
Holders
159
Holding in Top 10
2
Calls
$311K
Puts
$386K
Top Buyers
| 1 | +$9.89M | |
| 2 | +$4.04M | |
| 3 | +$3.57M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$2.08M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.89M |
Top Sellers
| 1 | -$3.1M | |
| 2 | -$2.52M | |
| 3 | -$2.09M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$1.74M |
| 5 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
-$1.68M |